Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 07:44 am Sale | 2022-12-31 | 13G | SAVERONE 2014 LTD ADS REPSTG O SVRE | Iroquois Capital Management, LLC | 81 4.450% | -64 (-44.14%) | Filing History |
| 2023-02-14 07:40 am Sale | 2022-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Iroquois Capital Management, LLC | 590 6.470% | -136 (-18.73%) | Filing History |
| 2023-02-13 08:03 am Purchase | 2022-12-31 | 13G | CHARLIES HLDGS INC CHUC | Iroquois Capital Management, LLC | 17,826,738 8.000% | 2,975,352 (+20.03%) | Filing History |
| 2022-08-15 5:38 pm Purchase | 2022-08-15 | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management, LLC | 1,389,869 6.700% | 12,400 (+0.90%) | Filing History |
| 2022-07-15 07:46 am Purchase | 2022-07-06 | 13G | SAVERONE 2014 LTD ADS REPSTG O SVRE | Iroquois Capital Management, LLC | 145 5.370% | 145 (New Position) | Filing History |
| 2022-07-11 5:11 pm Purchase | 2022-07-07 | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management, LLC | 1,377,469 6.600% | 118,678 (+9.43%) | Filing History |
| 2022-06-23 3:40 pm Purchase | 2022-06-21 | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management, LLC | 1,258,791 6.700% | 210,145 (+20.04%) | Filing History |
| 2022-02-23 7:34 pm Sale | 2021-12-31 | 13G | AYRO INC AYRO | Iroquois Capital Management, LLC | 8,856 4.990% | -4,165 (-31.99%) | Filing History |
| 2022-02-23 4:48 pm Purchase | 2021-12-31 | 13G | BLUE EARTH, INC. BBLUQ | Iroquois Capital Management, LLC | 156,445 0.900% | 31,310 (+25.02%) | Filing History |
| 2022-02-23 4:45 pm Sale | 2021-12-31 | 13G | MYMD PHARMACEUTICALS INC QCLS | Iroquois Capital Management, LLC | 726 9.560% | -315 (-30.26%) | Filing History |
| 2022-02-23 4:42 pm Sale | 2021-12-31 | 13G | SYNTHETIC BIOLOGICS INC SYN | Iroquois Capital Management, LLC | 230,870 1.920% | -30,000 (-11.50%) | Filing History |
| 2022-02-23 4:39 pm Purchase | 2021-12-31 | 13G | OBLONG INC OBLG | Iroquois Capital Management, LLC | 2,018 3.780% | 1,051 (+108.69%) | Filing History |
| 2022-02-23 4:36 pm Sale | 2021-12-31 | 13G | ARTELO BIOSCIENCES INC CO ARTL | Iroquois Capital Management, LLC | 370 0.240% | -3,037 (-89.14%) | Filing History |
| 2022-02-23 4:29 pm Unchanged | 2021-12-31 | 13G | HOTH THERAPEUTICS INC HOTH | Iroquois Capital Management, LLC | 50,633 4.990% | 0 (Unchanged) | Filing History |
| 2022-02-23 4:25 pm Purchase | 2021-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 4,777 4.990% | 1,880 (+64.89%) | Filing History |
| 2021-11-04 07:38 am Purchase | 2021-10-27 | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management, LLC | 1,048,646 5.100% | 1,048,646 (New Position) | Filing History |
| 2021-10-22 06:51 am Purchase | 2021-10-18 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 2,897 9.990% | 2,897 (New Position) | Filing History |
| 2021-09-21 4:30 pm Sale | 2021-08-04 | 13G | CHARLIES HLDGS INC CHUC | Iroquois Capital Management, LLC | 14,851,386 6.400% | -467,435,170 (-96.92%) | Filing History |